Ocean Biomedical, Inc. Common Stock
OCEA
OCEA was delisted on the 23rd of April, 2025.
25 hedge funds and large institutions have $247K invested in Ocean Biomedical, Inc. Common Stock in 2025 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 6 closing their positions.
100% more call options, than puts
Call options by funds: $2K | Put options by funds: $1K
50% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 6
14% more funds holding
Funds holding: 22 → 25 (+3)
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
88% less capital invested
Capital invested by funds: $2.01M → $247K (-$1.76M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$104K |
| 2 |
VPIM
Vanguard Personalized Indexing Management
Oakland,
California
|
+$62.2K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$45.7K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$23.5K |
| 5 |
RWP
Revolve Wealth Partners
Hackensack,
New Jersey
|
+$16.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$69.1K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$11.3K |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$11.1K |
| 4 |
AA
ACT Advisors
Asheville,
North Carolina
|
-$8.8K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$3.28K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AA
26
ACT Advisors
Asheville,
North Carolina
| – | -$8.8K | -15,911 | Closed |
|
|
TRCT
27
Tower Research Capital (TRC)
New York
| – | -$3.05K | -5,511 | Closed |
|
28
Fidelity Investments
Boston,
Massachusetts
| – | -$438 | -792 | Closed |
|
|
FFA
29
Farther Finance Advisors
San Francisco,
California
| – | -$43 | -182 | -99% |
|
30
Simplex Trading
Chicago,
Illinois
| – | +$2.72K | +11,378 | +732% |
|
OCEA Hedge Fund Activity: Q1 2025 in Review
25 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Ocean Biomedical, Inc. Common Stock (OCEA) for Q1 2025, worth a combined $247K — down 88% from $2.01M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new OCEA positions and 6 closed out — a net gain of 3 holders — while 5 added to existing stakes and 5 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $104K. The largest seller was Millennium Management, exiting entirely with an estimated $69.1K sold.
- 25 institutional investors held Ocean Biomedical, Inc. Common Stock (OCEA) as of Q1 2025, up from 22 in Q4 2024.
- Funds reported $247K of Ocean Biomedical, Inc. Common Stock stock for Q1 2025, down 88% quarter-over-quarter.
- 9 funds opened new Ocean Biomedical, Inc. Common Stock positions in Q1 2025 and 6 closed out, a net change of +3 holders.
- The largest Ocean Biomedical, Inc. Common Stock buyer in Q1 2025 was Citadel Advisors, an estimated $104K added.
- The largest Ocean Biomedical, Inc. Common Stock seller in Q1 2025 was Millennium Management, an estimated $69.1K sold.
Based on aggregated 13F filings for Q1 2025.